LBP and non-small cell lung carcinoma: (84) used proteomic techniques to look for diagnostic markers for metastatic NSCLC and discovered significant differences in the levels of LBP in exosomes and circulation of patients with metastatic and non-metastatic NSCLC, indicating that LBP has the potential to act as a metastatic NSCLC biomarker.